United Therapeutics Wins Patent Litigation Against Liquidia

United Therapeutics secured a legal victory in its patent lawsuit against Liquidia after a federal judge denied Liquidia's motion to block a portion of United Therapeutics' legal claims. The motion concerned United Therapeutics' argument based on the "common ownership exception."